Daniela Schulz-Ertner

Summary

Affiliation: University of Heidelberg
Country: Germany

Publications

  1. ncbi Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques
    Daniela Schulz-Ertner
    Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Cancer 104:338-44. 2005
  2. ncbi Carbon ion radiotherapy of skull base chondrosarcomas
    Daniela Schulz-Ertner
    Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 67:171-7. 2007
  3. ncbi Particle radiation therapy using proton and heavier ion beams
    Daniela Schulz-Ertner
    Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    J Clin Oncol 25:953-64. 2007
  4. ncbi Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients
    Daniela Schulz-Ertner
    Department of Clinical Radiology, University of Heidelberg, Germany
    Strahlenther Onkol 179:598-605. 2003
  5. ncbi Temporal lobe reactions after radiotherapy with carbon ions: incidence and estimation of the relative biological effectiveness by the local effect model
    Ingmar Schlampp
    Department of Radiation Oncology, University of Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 80:815-23. 2011
  6. ncbi Influence of radiotherapy treatment concept on the outcome of patients with localized ependymomas
    Stephanie E Combs
    Neuro Radiation Oncology Research Group, Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 71:972-8. 2008
  7. ncbi Optimization of radiation therapy for locally advanced adenoid cystic carcinomas with infiltration of the skull base using photon intensity-modulated radiation therapy (IMRT) and a carbon ion boost
    Daniela Schulz-Ertner
    Department of Radiation Oncology, University of Heidelberg, Germany
    Strahlenther Onkol 179:345-51. 2003
  8. ncbi Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas
    Daniela Schulz-Ertner
    Department of Radiation Oncology, University of Heidelberg, Heidelberg
    Int J Radiat Oncol Biol Phys 68:449-57. 2007
  9. ncbi Results of carbon ion radiotherapy in 152 patients
    Daniela Schulz-Ertner
    Department of Clinical Radiology, University of Heidelberg, INF 400, 69120 Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 58:631-40. 2004
  10. ncbi Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas
    Daniela Schulz-Ertner
    Department of Clinical Radiology, University of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 56:391-8. 2003

Detail Information

Publications61

  1. ncbi Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques
    Daniela Schulz-Ertner
    Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Cancer 104:338-44. 2005
    ....
  2. ncbi Carbon ion radiotherapy of skull base chondrosarcomas
    Daniela Schulz-Ertner
    Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 67:171-7. 2007
    ..To evaluate the effectiveness and toxicity of carbon ion radiotherapy in chondrosarcomas of the skull base...
  3. ncbi Particle radiation therapy using proton and heavier ion beams
    Daniela Schulz-Ertner
    Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    J Clin Oncol 25:953-64. 2007
    ..Clinical trials investigating proton and carbon ion RT will be summarized and discussed in the context of their relevance to recent concepts of treatment with RT...
  4. ncbi Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients
    Daniela Schulz-Ertner
    Department of Clinical Radiology, University of Heidelberg, Germany
    Strahlenther Onkol 179:598-605. 2003
    ..To prospectively evaluate outcome and toxicity after carbon ion radiotherapy (RT) in chordomas and low-grade chondrosarcomas...
  5. ncbi Temporal lobe reactions after radiotherapy with carbon ions: incidence and estimation of the relative biological effectiveness by the local effect model
    Ingmar Schlampp
    Department of Radiation Oncology, University of Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 80:815-23. 2011
    ....
  6. ncbi Influence of radiotherapy treatment concept on the outcome of patients with localized ependymomas
    Stephanie E Combs
    Neuro Radiation Oncology Research Group, Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 71:972-8. 2008
    ..To assess the outcome of 57 patients with localized ependymomas treated with radiotherapy (RT)...
  7. ncbi Optimization of radiation therapy for locally advanced adenoid cystic carcinomas with infiltration of the skull base using photon intensity-modulated radiation therapy (IMRT) and a carbon ion boost
    Daniela Schulz-Ertner
    Department of Radiation Oncology, University of Heidelberg, Germany
    Strahlenther Onkol 179:345-51. 2003
    ..This treatment planning study investigates the physical advantage of combined photon intensity-modulated radiation therapy (IMRT) plus carbon ion boost compared to photon IMRT alone...
  8. ncbi Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas
    Daniela Schulz-Ertner
    Department of Radiation Oncology, University of Heidelberg, Heidelberg
    Int J Radiat Oncol Biol Phys 68:449-57. 2007
    ..The aim of this study was to evaluate the effectiveness and toxicity of carbon ion radiotherapy in chordomas of the skull base...
  9. ncbi Results of carbon ion radiotherapy in 152 patients
    Daniela Schulz-Ertner
    Department of Clinical Radiology, University of Heidelberg, INF 400, 69120 Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 58:631-40. 2004
    ..This study summarizes the experience with raster scanned carbon ion radiation therapy (RT) at the Gesellschaft für Schwerionenforschung (GSI), Darmstadt, Germany since 1997...
  10. ncbi Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas
    Daniela Schulz-Ertner
    Department of Clinical Radiology, University of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 56:391-8. 2003
    ..To investigate clinical feasibility and toxicity of combined photon and carbon ion radiotherapy in locally advanced adenoid cystic carcinomas (ACC) within a prospective Phase I/II trial...
  11. ncbi Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens
    Stephanie E Combs
    Neuro Radiation Oncology Research Group, Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 71:999-1005. 2008
    ..To evaluate toxicity and outcomes in patients with primary glioblastoma (GB) treated with postoperative radiochemotherapy (RCHT) with temozolomide (TMZ) comparing two dose regimens...
  12. ncbi Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas
    Stephanie E Combs
    Neuro Radiation Oncology Research Group, Department of Radiation Oncology, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany
    J Neurooncol 89:205-10. 2008
    ..To evaluate outcome after fractionated stereotactic radiotherapy (FSRT) and concomitant daily temozolomide (TMZ) in patients with recurrent gliomas...
  13. ncbi Reirradiation of recurrent WHO grade III astrocytomas using fractionated stereotactic radiotherapy (FSRT)
    Stephanie E Combs
    Department of Radiation Oncology German Cancer Research Center DKFZ, INF 280, Heidelberg, Germany
    Strahlenther Onkol 181:768-73. 2005
    ..To assess the effect of reirradiation in recurrent WHO grade III astrocytomas...
  14. ncbi Acute toxicity of combined photon IMRT and carbon ion boost for intermediate-risk prostate cancer - acute toxicity of 12C for PC
    Anna V Nikoghosyan
    Department of Radiation Oncology, University of Heidelberg, Germany
    Acta Oncol 50:784-90. 2011
    ....
  15. ncbi Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base
    Stephanie E Combs
    Department of Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany
    Cancer 115:1348-55. 2009
    ..The current study was conducted to evaluate the outcome of carbon ion radiotherapy (RT) in children and young adults with skull base chordomas and chondrosarcomas...
  16. ncbi Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study
    Stephanie E Combs
    Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Strahlenther Onkol 181:372-7. 2005
    ..To evaluate the feasibility and toxicity of irradiation and concomitant administration of 50 mg/m(2) temozolomide in patients with primary malignant glioma, this phase I/II study was conducted...
  17. ncbi Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors
    Stephanie E Combs
    University Hospital of Heidelberg, Department of Radiation Oncology, Heidelberg, Germany
    Radiother Oncol 88:177-82. 2008
    ..No significant difference in overall survival or progression-free survival between both groups was calculated. RCHT seems not to result in an improved outcome. Further randomized studies are needed to support these results...
  18. ncbi Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors
    Stefanie Milker-Zabel
    Department of Clinical Radiology, Radiation Therapy, University of Heidelberg, INF 400, D 69120 Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 61:809-16. 2005
    ..To analyze our long-term experience and prognostic factors after fractionated stereotactic radiotherapy (FSRT) in patients with benign or atypical intracranial meningioma...
  19. ncbi Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients
    Stephanie E Combs
    Department of Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 70:987-92. 2008
    ..To evaluate efficacy and toxicity in elderly patients with glioblastoma multiforme (GBM) treated with postoperative radiochemotherapy with temozolomide (TMZ)...
  20. ncbi Carbon ion radiation therapy for high-risk meningiomas
    Stephanie E Combs
    Department of Radiation Oncology, University Hospital of Heidelberg, 69120 Heidelberg, Germany
    Radiother Oncol 95:54-9. 2010
    ..We analyzed outcome after a carbon ion boost in combination with precision photon radiation therapy in patients with meningiomas...
  21. ncbi Evaluation of therapeutic potential of heavy ion therapy for patients with locally advanced prostate cancer
    Anna Nikoghosyan
    Division of Radiation Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 58:89-97. 2004
    ..To investigate the feasibility of raster scanned heavy charged particle therapy in the treatment of prostate cancer (PCa,) with special regard to the influence of internal organ motion on the dose distribution...
  22. ncbi Fractionated stereotactic radiotherapy in low-grade astrocytomas: long-term outcome and prognostic factors
    Christian Plathow
    Division of Radiation Oncology, German Cancer Research Center, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 57:996-1003. 2003
    ..To evaluate outcome after fractionated stereotactic radiotherapy (RT) of patients with World Health Organization Grade 2 astrocytoma in terms of progression-free survival, overall survival, toxicity, quality of life, and prognostic factors...
  23. ncbi Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I/II trial: study protocol
    Stephanie E Combs
    Department of Radiation Oncology, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
    BMC Cancer 6:133. 2006
    ..Therefore, addition of EGFR-inhibition with cetuximab to the current standard treatment approach with radiotherapy and TMZ seems promising...
  24. ncbi Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes
    Stephanie E Combs
    University of Heidelberg, Department of Radiation Oncology, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
    Radiat Oncol 1:23. 2006
    ..The aim of the study was to evaluate the clinical outcome of intensity modulated radiotherapy (IMRT) in 46 patients with paranasal sinus tumors with special respect to treatment-related toxicity...
  25. ncbi Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution
    Stephanie E Combs
    Department of Radiation Oncology, University of Heidelberg, INF 400, 69120 Heidelberg, Germany
    J Clin Oncol 23:8863-9. 2005
    ..To evaluate the efficacy of fractionated stereotactic radiotherapy (FSRT) performed as reirradiation in 172 patients with recurrent low- and high-grade gliomas...
  26. ncbi Radiotherapy for chordomas and low-grade chondrosarcomas of the skull base with carbon ions
    Daniela Schulz-Ertner
    Department of Radiation Oncology, University of Heidelberg, INF 400, Heidelberg 69120, Germany
    Int J Radiat Oncol Biol Phys 53:36-42. 2002
    ..Compared to photon irradiation, carbon ions provide physical and biologic advantages that may be exploited in chordomas and chondrosarcomas...
  27. ncbi Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas
    Stephanie E Combs
    Department of Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 81:1415-21. 2011
    ..To evaluate the correlation between the 1993 and 2000/2007 World Health Organization (WHO) classification with the outcome in patients with high-grade meningiomas...
  28. ncbi Fractionated stereotactic conformal radiotherapy in the management of large chemodectomas of the skull base
    Angelika Zabel
    Department of Radiotherapy, German Cancer Research Center, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 58:1445-50. 2004
    ..To evaluate the role of fractionated stereotactic conformal radiotherapy (FSRT) as a noninvasive method in the management of large chemodectomas of the skull base...
  29. ncbi Fractionated stereotactic radiation therapy in the management of primary oligodendroglioma and oligoastrocytoma
    Stephanie E Combs
    Department of Radiation Oncology, German Cancer Research Center, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 62:797-802. 2005
    ....
  30. ncbi On the cost-effectiveness of Carbon ion radiation therapy for skull base chordoma
    Oliver Jäkel
    Department of Medical Physics in Radiation Oncology, Heidelberg, Germany
    Radiother Oncol 83:133-8. 2007
    ..The cost-effectiveness of Carbon ion radiotherapy (RT) for patients with skull base chordoma is analyzed...
  31. ncbi Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM)
    Stephanie E Combs
    Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Cancer 104:2168-73. 2005
    ..This article describes the results of a study of stereotactic radiosurgery (SRS) in the treatment of patients with recurrent malignant glioma...
  32. ncbi Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma
    Claudia Blattmann
    Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Im Neuenheimer Feld 154, 69120 Heidelberg, Germany
    BMC Cancer 10:96. 2010
    ..They achieve a higher relative biological effectiveness. Phase I/II dose escalation studies of HIT in adults with non-resectable bone and soft tissue sarcomas have already shown favorable results...
  33. ncbi Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery
    Stephanie E Combs
    Department of Radiation Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany
    Strahlenther Onkol 180:590-6. 2004
    ..To elucidate the role of SRS in this context, a retrospective study evaluating the benefit of SRS and prognostic factors for survival was performed...
  34. ncbi Local high-dose radiotherapy and sparing of normal tissue using intensity-modulated radiotherapy (IMRT) for mucosal melanoma of the nasal cavity and paranasal sinuses
    Stephanie E Combs
    Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Strahlenther Onkol 183:63-8. 2007
    ..To evaluate the clinical outcome of intensity-modulated radiotherapy (IMRT) in patients with mucosal melanoma (MM) of the nasal cavity and paranasal sinuses...
  35. ncbi Precision radiotherapy for hemangiopericytomas of the central nervous system
    Stephanie E Combs
    Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Cancer 104:2457-65. 2005
    ..The present analysis evaluates the role of precision RT in the management of HAP of the central nervous system (CNS) and represents one of the largest series of HAP treated with RT that can be found in the literature...
  36. ncbi Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas
    Stephanie E Combs
    Department of Radiation Oncology, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 76:193-200. 2010
    ..To evaluate the outcomes of patients with vestibular schwannoma (VS) treated with fractionated stereotactic radiotherapy (FSRT) vs. those treated with stereotactic radiosurgery (SRS)...
  37. ncbi Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT)
    Stephanie E Combs
    Department of Radiation Oncology, University of Heidelberg, INF 400, 69120 Heidelberg, Germany
    BMC Cancer 6:222. 2006
    ..To assess the role of Fractionated Stereotactic Radiotherapy (FSRT) in the management of ependymomas...
  38. ncbi Carbon ion radiation therapy for chordomas and low grade chondrosarcomas--current status of the clinical trials at GSI
    Daniela Schulz-Ertner
    Dept of Clinical Radiology, University of Heidelberg, Heidelberg, Germany
    Radiother Oncol 73:S53-6. 2004
    ....
  39. ncbi Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution
    Stephanie E Combs
    Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 63:75-81. 2005
    ..To assess the long-term outcome and toxicity of fractionated stereotactic radiotherapy for acoustic neuromas in 106 patients treated in a single institution...
  40. ncbi Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma
    Stephanie E Combs
    University of Heidelberg, Department of Radiation Oncology, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
    BMC Cancer 7:177. 2007
    ....
  41. ncbi In vitro responsiveness of glioma cell lines to multimodality treatment with radiotherapy, temozolomide, and epidermal growth factor receptor inhibition with cetuximab
    Stephanie E Combs
    Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 68:873-82. 2007
    ..The majority of glioblastoma multiforme (GBM) cells express the epidermal growth factor receptor (EGFR). The present study evaluates the combination of temozolomide (TMZ), EGFR inhibition, and radiotherapy (RT) in GBM cell lines...
  42. ncbi Fractionated stereotactic radiotherapy of optic pathway gliomas: tolerance and long-term outcome
    Stephanie E Combs
    Department of Radiation Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 62:814-9. 2005
    ..To evaluate the effectiveness and toxicity of fractionated stereotactically guided radiotherapy (FSRT) in the management of optic glioma...
  43. ncbi Long-term outcome of high-precision radiotherapy in patients with brain stem gliomas: results from a difficult-to-treat patient population using fractionated stereotactic radiotherapy
    Stephanie E Combs
    Department of Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany
    Radiother Oncol 91:60-6. 2009
    ..To assess long-term outcome in 85 patients with brain stem gliomas treated with fractionated stereotactic radiation therapy (FSRT)...
  44. ncbi Fractionated stereotactic radiotherapy for craniopharyngiomas
    Daniela Schulz-Ertner
    Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 54:1114-20. 2002
    ..To investigate outcome and toxicity after fractionated stereotactic radiation therapy (FSRT) in patients with craniopharyngiomas...
  45. ncbi Treatment outcome after linac-based radiosurgery in cerebral arteriovenous malformations: retrospective analysis of factors affecting obliteration
    Angelika Zabel
    Department of Radiotherapy, German Cancer Research Center, Heidelberg, Germany
    Radiother Oncol 77:105-10. 2005
    ..We investigated patient outcome and factors affecting obliteration rate after radiosurgery in cerebral arteriovenous malformations (AVM)...
  46. ncbi Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003--a single institution's experience
    Eva Maria Stoiber
    Department of Radiation Oncology, University Hospital Heidelberg, INF 400, 69120 Heidelberg, Germany
    Radiat Oncol 5:122. 2010
    ..To evaluate the effectivity of fractionated radiotherapy in adolescent and adult patients with pineal parenchymal tumors (PPT)...
  47. ncbi The role of radiation therapy in the management of desmoid tumors
    Daniela Schulz-Ertner
    Department of Radiation Oncology, University of Heidelberg, Germany
    Strahlenther Onkol 178:78-83. 2002
    ..To investigate the role of radiation therapy (RT) in the management of desmoid tumors...
  48. ncbi Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy
    Stephanie E Combs
    Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Cancer 109:2308-14. 2007
    ..The long-term outcome in patients with craniopharyngiomas treated with fractionated stereotactic radiotherapy (FSRT) was evaluated...
  49. ncbi Long-term outcome of stereotactic radiosurgery (SRS) in patients with acoustic neuromas
    Stephanie E Combs
    Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 64:1341-7. 2006
    ..To evaluate the effectiveness and long-term outcome of stereotactic radiosurgery (SRS) for acoustic neuromas (AN)...
  50. ncbi A clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma
    Falk Roeder
    Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany
    BMC Cancer 12:287. 2012
    ....
  51. ncbi Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET
    Stefanie Milker-Zabel
    Department of Radiation Oncology, Radiation Therapy, University of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 65:222-7. 2006
    ..Because meningiomas show a high expression of somatostatin receptor subtype 2, somatostatin analogs such as DOTATOC offer the possibility of receptor-targeted imaging...
  52. ncbi Long-term outcome of postoperative irradiation in patients with newly diagnosed WHO grade III anaplastic gliomas
    Monika Nagy
    Department of Radiation Oncology University Hospital of Heidelberg, Heidelberg, Germany
    Tumori 95:317-24. 2009
    ..In most analyses, WHO grade III and 1V tumors are not analyzed separately. The present analysis reports outcome after postoperative radiotherapy in patients with WHO grade III gliomas...
  53. ncbi Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines
    Stephanie E Combs
    Department of Radiation Oncology, University of Heidelberg
    Int J Radiat Biol 85:126-37. 2009
    ..To investigate the cytotoxic effect of high linear-energy transfer (LET) carbon irradiation on glioblastoma cells lines in combination with temozolomide (TMZ)...
  54. ncbi Radiotherapeutic alternatives for previously irradiated recurrent gliomas
    Stephanie E Combs
    University Hospital of Heidelberg, Department of Radiation Oncology, Im Neuenheimer Feld 400, 69120 Heidelberg, German
    BMC Cancer 7:167. 2007
    ....
  55. ncbi Radiotherapy in the treatment of primary osteosarcoma--a single center experience
    Susanne Oertel
    Department of Radiooncology, University Clinic Heidelberg, Germany
    Tumori 96:582-8. 2010
    ..To analyze our experiences concerning radiation treatment in patients with osteosarcoma...
  56. ncbi Radiation therapy with charged particles
    Daniela Schulz-Ertner
    Department of Radiation Oncology, University of Heidelberg, Germany
    Semin Radiat Oncol 16:249-59. 2006
    ....
  57. ncbi Acute radiation-induced toxicity of heavy ion radiotherapy delivered with intensity modulated pencil beam scanning in patients with base of skull tumors
    Daniela Schulz-Ertner
    Department of Clinical Radiology, University of Heidelberg, Heidelberg, Germany
    Radiother Oncol 64:189-95. 2002
    ..No unexpected acute dose limiting toxicity was observed. With regard to toxicity, a substantial improvement compared to passive beam shaping technology is achieved...
  58. ncbi Follow-up gliomas after radiotherapy: 1H MR spectroscopic imaging for increasing diagnostic accuracy
    Matthias Philipp Lichy
    Department of Radiology, German Cancer Research Center, Heidelberg, Germany
    Neuroradiology 47:826-34. 2005
    ..We conclude that 1H SI is helpful in characterising new suspicious lesions in irradiated gliomas, particularly if pre-MRI is not available for evaluating follow-up...
  59. ncbi Intensity-modulated radiotherapy of sacral chordoma--a case report and a comparison with stereotactic conformal radiotherapy
    Christoph Thilmann
    Department of Radiotherapy, German Cancer Research Center, Heidelberg
    Acta Oncol 41:395-9. 2002
    ..The volume of bowel receiving a dose higher than 40 Gy was reduced from 400 cc with CRT to 220 cc with IMRT. If particle therapy is not available, IMRT seems to be a promising alternative in the treatment of sacral chordomas...
  60. ncbi Influence of setup errors on spinal cord dose and treatment plan quality for cervical spine tumours: a phantom study for photon IMRT and heavy charged particle radiotherapy
    Christian P Karger
    Deutsches Krebsforschungszentrum, Abteilung Medizinische Physik Im Neuenheimer Feld 280, D 69120 Heidelberg, Germany
    Phys Med Biol 48:3171-89. 2003
    ..Dose distributions produced with carbon ions, however, are more sensitive to setup errors, which have to be considered during treatment...
  61. ncbi Comments to the forum of M. Goitein
    Christian P Karger
    Z Med Phys 14:200; author reply 201. 2004